IL1B and hyperuricemia: Berberrubine has been shown to significantly reduce serum urate levels and the levels of inflammatory mediators (IL-1β, IL-6, and TNF-α) in mice with PO- and hypoxanthine-induced hyperuricemia (Lin et al., 2021).